We investigated the clfcet of ad mln isu,lIio n of somatotropi n (ST) and/or cCG on insul io ·like growth faClo r I (IGF·I) and IGF· binding p rou:ills ( IGFBP) '0 seru m and fo llicular Huid (I'I'L) of caul e aClive'y immunizc:d agail'lSt growth ho rmo ne·releasing faclor (GRf). Cyelic beef canle, p reviously immuni~ed agahl!il GRF{ 1-29}Gly·G ly·Cys·NH, conjugliled to hu man serum al bumi n (syn· thesized and provided by tlotrmano·LaRocbc, Inc., Nutley. /' 10; GRfi. n "" 3 1) o r to hu man serum albumin alone ( HSAi, n '" 26), received (L m.): I) 25 mg rccombinm tly deri\'ed mcthiooyl somatouopln (rbST, II = 14; somelribove provided by Monsanto Co., St. Louis, MO); 2) 1100 IU c:CG ( n '" 10), 3) rbST and cCG (rbST-d:G, n = 15); or 4) "chide (VEH, n "" 17) at 0 and 24 b after receiving pl'O!'ilagiandln 1'... (PG Floo ). Saum samples were: COllected at 0 and 40 h after PGF ... , and me: ovary bearing me: largest foUide (ooM ) was n;moved 44.0 :t: 0 .5 h alter PGF ... , FFL _ h1l'VC$tcd from 00-'1 and the subordioate foUiele (SUB). Ikfore: treatment (0 h). GRFi <:ows h3d lowff serum ST (0.6 ;t; 0.2 V$. 2.2 ;t; 0 .2 ng/ ml; p < 0,01 ) and IGF·I (26 :t: 4 V$. 72 ;t; 4 ng/mJ;p < 0,01). but gte ller IGFBP·2 (594 :t: 48 V$. 384 ;t; 52 ng/ml,p < O.oJ) m;an HSAi cows. Sc:rum and FFL concentrations of IGI'·J or IGfBp·2 were: 00( different bc;",,'ec:n rbST· and rbST<CG·tr(:alcd cows or bc:twcc:n VEH-and cCG·trcatcd cows at Hour 40 aftC1' the io itial tte2tmc:n t inje<:tlon; therefore::. data were combined and designated as rbST and VEH. rc:spc:cti..cly. Serum IGF·I ~'3.S increased to a greater ex tent (pcrceotagc: incrca.\C: above: 0 h ) by rhST treatment in GRFI (362 ;t; 24) tlwi in HSAI ( 176:t: 16) cows (i mm uni7,a tion by UU lm Cllt,p < 0.01). Across GRFi ;and HSAi, rbST lowc:tt.'d serum IGFB P·2 (342:t: 31 vs. 54 1 ± 27 ng/ml, rbST V5. VEil: p < 0 .0 1)_ Di;uneters of DOM or SUB were no t aJJccted by lmmunlutlon o r treatme nt. Con· centrations of IGF·' and IGFB P·3 (dctt'1Tl1incd by ligand b lot aoalysis ) in FFL from both DOM and SUB wen: lower (p < 0 .05)
INmQDUCTlON
progesterone (P4) and oxytocin to values greater than those obtained with FSH alone in bovine granulosa cells. Fur SomatotrOpin (ST) is a key regulator of somatic growth.
thermore, gonadolropins increase IGF-I secretion by por In ruminants, hypophysectomy [1] or active immunization cine granulosa cells (1l). IGFBP have been shown to inhibit againSt growth hormone-releasing factor (GRF) (2) (3) (4) In Ihe presence of insulin, ST has been shown to en cific binding prOteins (lGFBP), which modulate their func· hance cell growth in OOvine in vitro<ullured granulosa cells tion [6] .
[14J and p. produaio n in bovine [14] and porcine [15] in In vitro studies have shown that IGF-I enhances FSH· vitro-cultured granulosa cells. Jia et al.
[16J have demon slimulated steroid productio n in murine [7J and porcine strated that ST augments gonadotropin-stimulated differ granulosa cells [8, 9] . Schams [10J has shown that IGF·I in entiation or in vitro-cultured granu losa cells obtained from creases, in a dose-<tependent manner, the production of immature ratS. In vivo effects of ST on ovarian function have Ix!cn studied in cattle (4, [17] [18] [19] [20] [21] and prepubertal gi lts (22 Aaqlttd Septcni:>er 20. 1993 .
2S], but the results have been variable. Active immunization
RettMd february 17, 1993. against GRF has been shown to decrease serum Sf and IGF I and to dela), puberty in beef heifers [3, 4 ) . Heifers im names in this publicalion doe$ noo: Impl)' er>dol~mem by the North carolina AIlS munized against GRF that failed 10 reach puberty by 18.5 nor crkklsrn of similar produos noo: mentioned. mo of age had lower serum IGF-I concemrations at the time of primary GRF immunizatio n (6 mo of age). We admin 290 SERUM ANO fOlLICUlAR IGF-I AND IGFRPs IN UTILE istered ST and/or eCG (0 beef cows that had been previ ously immunized against GRF to clarify (he interactions be tween ST, IGF-J, IGFBP, and gonadotropins at the level of the ovary. Specifically, our objective was 10 quantify IGF-I and IGFBP in fo llicular fluid (FA..) fro m cyclic cows with e levated, normal, or low serum ST and IGF-I.
MATERIALS AND METHODS
Cyclic nulliparous and primiparous Angus and Charolais (n = 43) [3, 26] or multiparous Angus and Hereford (n ' "" 12) females [27J, previously immunized. against GRF or hu man serum albumin, were used. The 2-to 3-yr-old Angus and CharoJais cows weighed 407 ± 11 and 440 ± 14 kg, respeaively. The multiparous Angus and Hereford cows were 5-6 yr of age and weighed 475 ± 31 kg. Cows were im munized with 1.5 mg GRF-(1-29)-Gly-Gly-Cys·NH z conju gated to 1.5 mg human serum albumin (GRFi j Hoffma nn La-Roche, Inc., Nutley, NJ) or with 1.5 mg human serum albumin ( HSAij Sigma Chemical Co., 5t. Louis, MO) at 6 mo of age [3, 26] or at 3-4 yr of age [27J. Cows were admin istered booster immunizatio ns as p revio usly described [3, 26, 27J ; however, the most recent booster immunization \\-"Quld have been given at least 3 mo before initiation of this study. A final booster injection was given 4 wk before the study began.
Estrous cycles were synchronized by three i.m. injec tions of prostaglandin F:z.:, (PGF2cJj Lutalyse, Upjohn, Kala mazoo, MI) given 14 days apan ( 1000-1400 h). Prior to synchronization, cows were maintained on grass-legume pasture. At the time of the fi rst PGF:z.:, injection, cows were moved to open-sided pens with sloned floors (30 m X 9 m). CO"ws were fed a diet of sorghum silage and concen trate calculated to proVide 100% of NRC recommendations [28J for a 5OQ.-kg mature, nonlactating beef cow. Cows were divided randomly within breed (Angus, Charolais, or Here ford) and immunization status (GRFi, n "" 31,398 ± 18 kg; or HSAi, n == 26, 443 ± 9 kg) into one of four treatment groups: 1) rbST: i.m. injection (25 mg) of rbST (sometri bove; Monsanto Co., 51. Louis, MO) (GRFi-rbST, n "" 10; HSAi-rbST, n = 4); 2) eCG: i.m. injeaion ( 11 00 IV) of eCG (Diosynth Inc., Chicago, IL) (GRFi-eCG, n == 5; HSAi-eCG, n = 6); 3) rbST-eCG: i.m. injeaio ns of rbST (25 mg) and eCG ( 11 00 IU) (GRFi-rbST-eCG, n = 6; HSAi-rbST-eCG, n = 9): or 4) VEH: i.m. injection (2.5 ml) of sterile 35 mM NaHCO, (Sigma) (GRFi-VEH, n "" 10; H5Ai-VEH, n == 7). We ensured that 4-6 cows were in each creatment; excess animals were allocated to rbST and VEH treatments. The dosage of eCG specified above was used to achieve follic ular stimulation without superovulatio n [291. Cows received the ir respective treatments at 0 and 24 h from the last in jectio n o f PGF:z.:,. Procedures were approved by the North Carolina State University Animal Care and Use Comminee.
Approximately 44.0 (± 0.5) h after the last injection of PGF 20 , ovaries were examined via the rectum by real-time ultrasound (Aloka 500V; Corometrics Medical Systems, Inc., Wallingford, CT) using a 7.5-MHz transducer (Aioka, UST· 660-7.5; CorOmetrics). Time after PGF2cJ was based on a preliminary experiment in which ovaries were removed at 24 or 48 h after PGF2cJ administration. Epidural anesthesia was produced by infiltrating the epidural space between the last sacral and first caudal vertebrae with 5 ml of 2% lidocaine HCI (Lidocaine; Sigma-Aldrich Corp., Milwaukee, WI). Once identified, the ovary bearing the largest follicle was unilaterally removed by inserting an ecraseur through an incis io n in the dorsal wall of the vagina. Cows thai had ovulated were excluded. Ovaries were placed on ice and transported to the IaOOratory. Diameters of the largest (OOM) and subordinate fo llicle (SUB), on the single ovary re moved, were recorded; DOM was dissected free of ovarian stroma, and ffi was aspirated from OOM and SUB. FFl. was centrifuged at 1500 x g for 15 min to remove cellular de· bris and then aspiraced and stored at -2ifC until analyzed fo r IGF-I and IGFBP. All steps were completed within 30 min of ovarieaomy.
Blood samples were collected via jugular or coccygeal venipuncture three times per week during estrous syn ch ronization to monitor P 4 concentrations. Single blood samples were also collecr:ed before initiation of treaunem (0 h) and before ovariectomy (40 h). Blood samples were stored at 4°C for at least 8 h and centrifuged at 1500 x g for 30 min; serum was stored at -20°C until analyzed for ST, IGF-I, and IGFBP.
A5says
Serum concentrations of P 4 were determined using P 4 (P-OI30, Sigma) standards prepared in om M PBS-O.1% gel atin (G8-500; Fisher Scientific, Atlanta, GA) by a solid-phase RIA (Diagnostic Products Corp., Los Angeles, CA). Average intra· and imerassay coefficients of variatio n (CV) were 6.6 and 10.1 %, respectively, for five assays. Sensitivity, defined as 90% of total binding, was 0.5 ng/mi. Serum concentrations of ST were determined in a single assay by the procedure described by Armstrong and Spears [30] . Intraassay CV and sensitiVity, as described previously, were 9.6% and 0.6 ng/ml, respectively. Serum and FFL con· centrations of IGF-I were determined as described by 
Sta/isJical Analyses
All analyses were conduaed by means of GLM proce· dures (371. Ho rmone data from serum colleaed at 0 and 40 h were analyzed using a model containing immunization (GRFi vs. HSAi), treatment (VEH, rbST, ECG, rbST-ECG), immunization by treatment, cow within immunization by treatment, hour, immunization by hour, treatment by hour, and immunization by treatment by hour. The effects of im munization, treatment, and immunization by treatment \\'ere tested using cow within immunization by treatment mean square as the error term. Initial analyses revealed that nei ther breed nor imeracrions involving breed were signifi· cant; thus effects involving breed were o mitted from sub sequent analyses. Due to the pretre-dtmem diffe rence in serum IGF-I be(Ween GRFi and HSAi, serum IGF-I concen trations at 40 h were expressed as percentage of pretreat ment serum IGF-L Treatment means were compared by Student Newman-Keuls test using cow within immunizatio n by treatment as the error term.
Hormone concentrations from FFl.. (lGF-I and IGFBP-2) were analyzed through use of a model containing immu nizatio n, treatment, and immun izatio n by treatment. Initial analyses revealed that neither breed nor interactions in· volving breed were significant; thus effectS involving breed were omitted from subsequent analyses. Diameter, diam eter by treatment, and diameter by immuni7..ation were In cluded as covariatesj covaoates not contributing to varia lion (p > 0.1) were deleted from subsequent analyses. for all honnones anaJyt.ed. Therefore these U'eaunems were combined for presentation (represented as VEH).
Mean concentrations of serum ST at 0 h were lower (p < 0.01) in GRFi (0.6 ± 0.2 ng/ml) than in HSAi (2.2 ± 0.2 ng/ml) cows (Fig. 1) . However, 40 h after initiation oftreat ments, serum ST was similar (p > 0.1) in GRFi (10.0 ± 0.8 ng/ml) and HSAi (10.6 ± 0.8 ng/ml) cows (Fig. 1) . Across Before treaunem, serum concentrations of fGFBP-2 were significantly greater in GRFi than in HSAi cows (594 ± 48 vs. 384 ± 52 ng/m l, respectivelYi Fig. 3 ). After treatment with rbST, serum IGFBP-2 was decreased in both GRFi (371 ± 34 ng/ml) and HSAi (3 14 ± 27) cows ( Fig. 3) sented in Figure 4 . FR concentrations of IGF-I (ng/ml) in OOM and SUB were lower (p < 0.05) in GRFi (88.6 ± 8 and 108 ± 11 , respeaively) man in HSAi (107 ± 6 and 127 ± 8, respeaively) cows ( Fig. 4) . Regardless of immuniza Ligand blot analysis of ffi and serum revealed multiple bands mat round [12SIIIGF_I (Fig. 6 ). ImmunoblQl analyses with specific antibodies against IGH~Ps identified the 43 000 and 39 (XX) M. bands as IGFBP·3; the 34 (XX) M. band as IGFBP 2; and a 31 000-32 000 M, doublet as IGFBP·S (Fig. 5) . The additional band at Mr 24000 is likely to be IGFBP-4, bUI nO immunoblot was conducted to verify this. ImmunoblOI analysis also indicated that ffi from roth DOM and SUB contained two non-IGF binding IGFBP-2 fragments with ap proximate molecular weights of 22000 and 14000. Small amounts of IGFBP'5 fragmen! (apprOXimately 21 000 Mr) were also detectable in some samples. The relative inten sities of the IGFBP·2, -5, and -4 bands prescm in FA. from ooMwere not differem between GRn and HSAi cows (Fig. SUI 6, panels A and B), and considerable variation was ob served betwc..-en animals. However, with me exception of band imensities for one cow from each group, the imen· slUes of the IGFBP·2, '5, and 4 bands were markedly grealer in FA. from SUB of GRFi compared to HSAi anilT).11s (Fig.   6, panel C) . In contrast, me band intensities of IGFBP-3 de termined by scanning de nsito me try were lower for GRFi compared to HSAi animals with respect to FA.. from both OOM ( 12606 ± 2665 vs. 21 
DISCUSSION
ACtive immunization against GRF provides an effective means to uncouple GRF and ST [4 ~ Immunoncutralization of GRF abolishes e pisodiC release of ST and suppresses serum ST and lGF-I in cyclic gilts [38) , lactating sows [391, lactating cows [271, growing steers [2,40}, and he ifers [3] . Administration of I:xJoster immuni7..ations to GRFi cows maintained suppressed serum ST and JGF-I throughout the experiment ( Fig. 1 and 2) .
In the present study, administration of rbST incre-ASed serum ST arove physiological levels at 40 h after initiation of treatme nt in cows with no rmal ( HSAi) o r suppressed (GRFi) ST (Fig. 1) . As would be expected, cows receiving rbST had increased concentrations of serum IGF·I by Hour 40; this increase elevated serum IGF-I to similar absolute levels in GRFi and HSAi cows (Fig. 2) . The greater per· centage incre-dSC in serum IGF-J observed in GRFi cows re ceiving rbST may indicate that GRFi cows are more sensi tive to rbST. Alternatively, the observation that {he absolute increase in IGF-J was s imilar in GRFi and HSAi cows may indicate that capacity for IGF-I synthesis and secretion is not altered by GRFi. Future studies will be required to clar ify these possibilities. Delayed puberty has been observed in GRFi he ifers in association with low serum IGF-I (3, 4] and in plerocercoid treated female rats in association with depressed serum ST 141). In the present study, aCtive immunization against GRF lowered FA. concentratiOn') of IGF-J in the DOM and SUB follicle . however. magnitude o f difference was not as pro nounced as that observed in serum ( Figs. 2 and 4) . Since IGF-I has been proposed as a local regulatOr of ovarian funCtion (7, 9] , a decrease in FA. IGF-I may also be involved in the delay of puberty observed in GRFi heifers. It is equally possible that GRFi may decrease ST in m to levels s imilar to that observed in serum. On the basis of previous reports (43] , one would expeCt transudation o f ST from serum to FFL Although FFL ST concentration was not measured in the current study, our laboratory has demonslrated the presence of GRF antibodies in FFl, al Ie\-els > 90% of that detected in serum, aspirated from GRFi cows (42J. We therefore specutare that ffi ST woukl be correlated to serum ST concenlration in the present study.
DOM taken from cows receiving rbST had greater con cenlrations of IGF-I regardless of immunization Status (Fig.  4) . This agrees with studies in gilts in which administration of porcine pituitary ST increased FFL and serum IGF-I con centrations (22, 24, 25] . Hammond et al. (44] reported that an increase in m IGF-I concentration is associated with increased fo llicular growth. Additio nally, FFL IGF-I levels have been shown to increase with follicular diameter (44, 451 , and twinning in cattle has been suggested to be associated with elevated serum and m IGF-I [46] . Neither a correla tion between follicular diameter and IGF-I nor a treatment by-diameter interaction was significant in the present study. (42) has been reported to significantly decrease plasma IGF-I conceOlra tions without affecting IGF-I concentrations in large folli cles. These data suggest that under cenain physiologic con ditions, IGF-l concentrallons may be regulated locally.
In the CutreOl study, eCG did not affect fo llicular IGF-I or IGFBP-2 concentrations. The lack of an effect may in d icate an insufficient eCG dosage resulting from our desire to avoid superovulation. However, the eCG used In this srudy was shown to be biologically active via increased ovulation rate in mice (29]. Concentrations of estradiol and P, in FFt could not be detennined because of inadequate sample volume. It has been indicated that the ovarian IGF system functiOns a~ an imponant local amplification mechanism for Steroidogenesis and gonadotropin action [7, 58] . Hsu and Hammond [11 1 have reported enhanced secretion of im munoreacm-e IGF-I by cultured pordoe granulosa cells when treated with LH and/or FSH. In 1'9.'0 separate studies, fol · licular IGF-I concentrations have been reported to increase during eCG-induced follicular growth in gilts {24, 59]. Ada shi e t al. (60] have shown the ability of FSH to regulate granulosa cell IGFBP in a dose-and time-dependent, but biphasic, manner. Studies conduCted in rodents concerning the effects of eCG on fo llicular IGF-I are difficult to inter pret, as such effects may be species-specific. Spicer et al. (45] reported minimal changes in IGF-I levels during spon taneous or GnRH-induced follicular development in post partum cattle.
Since In contrast [0 serum ST a nd IGF-I concentratio ns, cir culating IGl-"SP-2 conce ntrations were elevated in GRF-im munized cows. This is consisle nt with o bservations that .serum IGFBP-2 is elevated in humans [68] and in transgenic mice [691 with ST deficiency. In the presem study, rbST de creased serum IGFBP-2 in cows with normal ( HSAi) and suppressed (GRFi) serum ST while Simultaneously increa'> iog serum IGF-I (Fig. 3) . These data suggest that serum ST and/or IGF-I are mediators of serum IGFBP-2 concentra tions. Treatment with rbST has also been reponed to sig nificantly decrease .serum IGFBP-2 in iaaating dairy cows [34, 70) . In COntrast, infusion of IGF-I has been shown to induce IGFBP-2 in humans in vivo [71, 72] . The mecha nism(s) by which e ither ST or IGF-I mediates serum IGFBP 2 concentratio ns is presently unknown.
Conce ntrations of IGFBP-2 were e levated in both serum and FA. from SUB fo llicles o f cows immunized against GRF, and treatment with rbST decreased IGFBP-2 in serum as well as in FA. from DOM and SUB follicles of both GRFi and HSAi cows. Also, average concentratic;>ns of IGFBP-2 were greater in FA.. from SUB than in f'FL from OOM follicles or in serum. Collectively these data, coupled with the obser V' dtio n that IGFBP-2 is negative ly correlate d with follicular diameter, indicate that IGFBP-2 is synthesized at a higher rate in small follicles. However, all compartments (OOM, SUB and serum) may have been affected by changes in serum IGFBP-2, because IGFBP-2 decreased in all compartments following rbST. In contrast, GRFi increased levels of IGFBP 2, -5, and ·4 in FA. o f SUB but no t DOM, suggesting that regulation of these IGFBP in DOM may be occurring locally at me tL<;sue level. Ovarian tissue mRNA foc IGPBP-2 mrough -5 has been identified in the rat [73,74J, for IGFBP-2 and -3 in the pig [751. and for IGFBP-l through -3 in the human [76] . Furthermore, culture d granulosa and thee-,ll cells have been shown to synthesize IGFBP [76-78,62J . Therefore, changes in local producrion of IGFBP have the pote ntial to playa key role in regulating the availability of IGF to ovar ian cells. Addition of exogeno us IGFBP has been shown [ 0 inhibit the ability of FSH and IGF-I to stimulate steroido genesis, cAMP generation, and DNA synthesis in cu ltured granulosa cells [12, 79, 801 . Recently, IGF analogues with re duced affinities for IGFBP but no t the Type-I receptor were shown to be mo re effective than IGF-I in e nhancing FSH stimulated accumulatio n of P 1 by rat granulosa cells [811 and in stimulating IGfBP synthesis [82] . Since FSH a lso has been shown ' to inhibit the secretio n of IGFBP by granulosa cells [61, 62, 77] , this may represem a mechanism by which IGF availability is increased to promote granulosa cell growth. It is apparent that ST, IGf-l, and IGFBP are inte rre lated in serum and FA. of catlle. The presem study has prOVided evidence suggesting that IGF-I and IGFBP are differe mially regulated in DOM and SUB follicles in cycliC beef cows. How these ho rmo nes participate in attainment of puberty, fo lliculogenesis, and ovarian function is not understood, panirularly in vivo. Future studies are net..-'ded to clarify how interactions between IGF-I and IGF13P affea fo llirular growth. 
